Gilman Hill Asset Management LLC Buys Shares of 2,250 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Gilman Hill Asset Management LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,250 shares of the exchange traded fund’s stock, valued at approximately $203,000.

A number of other large investors have also made changes to their positions in XBI. Mission Hills Financial Advisory LLC raised its holdings in SPDR S&P Biotech ETF by 14.3% during the fourth quarter. Mission Hills Financial Advisory LLC now owns 36,111 shares of the exchange traded fund’s stock worth $3,252,000 after purchasing an additional 4,531 shares during the last quarter. Herbst Group LLC raised its stake in shares of SPDR S&P Biotech ETF by 19.9% during the 4th quarter. Herbst Group LLC now owns 4,830 shares of the exchange traded fund’s stock worth $435,000 after buying an additional 800 shares during the last quarter. Ameritas Advisory Services LLC boosted its position in shares of SPDR S&P Biotech ETF by 11.9% in the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after buying an additional 1,137 shares in the last quarter. Shelton Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 6.7% in the 4th quarter. Shelton Wealth Management LLC now owns 4,359 shares of the exchange traded fund’s stock valued at $393,000 after acquiring an additional 273 shares during the last quarter. Finally, Carnegie Investment Counsel increased its holdings in SPDR S&P Biotech ETF by 6.0% during the 4th quarter. Carnegie Investment Counsel now owns 101,106 shares of the exchange traded fund’s stock valued at $9,106,000 after acquiring an additional 5,683 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $87.97 on Tuesday. The firm’s 50-day moving average is $93.78 and its two-hundred day moving average is $96.96. The company has a market capitalization of $6.71 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.